Efficacy endpoints
tumor, SD
DISEASE, DISEASE PROGRESSION, TUMOR
The primary efficacy endpoint was the overall response rate (ORR), that is, the number of subjects with best objective response (complete response [CR] or partial response [PR]), divided by the number of subjects who participated in the analysis, which was determined by investigator assessment and based on RECIST version 1.1 criteria. Additional efficacy endpoints included percentage change in size of target lesion(s), duration of response (the time from documented tumor response [CR or PR] to disease progression), disease control rate (DCR: the sum of CR, PR, and stable disease [SD] rates), progression‐free survival (PFS), time to response (TTR), and overall survival (OS).